|
4 Companies |
|
2 Products |
|
2 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
49 News |
|
- || Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Phase classification, Enrollment change: Post Approval Commitment Study (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=305, Completed, Sponsor: Endo Pharmaceuticals
Phase classification: P4 --> P=N/A | N=250 --> 305
- | Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Phase classification: Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules (clinicaltrials.gov) - Oct 5, 2017
P2a, N=76, Completed, Sponsor: Endo Pharmaceuticals
Phase classification: P4 --> P=N/A | N=250 --> 305 Phase classification: P2 --> P2a
- || Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Phase classification: Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures (clinicaltrials.gov) - Oct 5, 2017
P3b, N=715, Completed, Sponsor: Endo Pharmaceuticals
Phase classification: P2 --> P2a Phase classification: P3 --> P3b
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion, Trial primary completion date: Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture (clinicaltrials.gov) - Oct 4, 2016
P=N/A, N=50, Completed, Sponsor: Jeppe Lange, MD
Phase classification: P3 --> P3b Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Oct 2016
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion, Trial primary completion date: Registry of Patient With M. Dupuytren and Validation of the Brief MHQ (clinicaltrials.gov) - Aug 22, 2016
P=N/A, N=60, Completed, Sponsor: Schulthess Klinik
Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Oct 2016 Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Jul 2015
- |||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion, Trial primary completion date: Post Approval Commitment Study (clinicaltrials.gov) - Jun 20, 2016
P4, N=250, Completed, Sponsor: Endo Pharmaceuticals
Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Jul 2015 Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Nov 2015
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial primary completion date: Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture (clinicaltrials.gov) - Oct 28, 2015
P=N/A, N=50, Active, not recruiting, Sponsor: Jeppe Lange, MD
Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Nov 2015 Trial primary completion date: Jan 2015 --> Nov 2015
- |||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial primary completion date: Administration of Two Injections for Multiple Dupuytren's Contractures (clinicaltrials.gov) - May 7, 2015
P3, N=60, Completed, Sponsor: Endo Pharmaceuticals
Trial primary completion date: Jan 2015 --> Nov 2015 Trial primary completion date: Jul 2012 --> Feb 2012
- ||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed: Post Approval Commitment Study (clinicaltrials.gov) - Apr 2, 2015
P4, N=250, Active, not recruiting, Sponsor: Endo Pharmaceuticals
Trial primary completion date: Jul 2012 --> Feb 2012 Recruiting --> Active, not recruiting
- | Trial completion: Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease (clinicaltrials.gov) - Mar 25, 2015
P3, N=72, Completed, Sponsor: State University of New York
Recruiting --> Active, not recruiting Not yet recruiting --> Completed
- Trial completion: Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease (clinicaltrials.gov) - Mar 25, 2015
P2, N=36, Completed, Sponsor: State University of New York
Not yet recruiting --> Completed Recruiting --> Completed
- |||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion, Trial primary completion date: Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules (clinicaltrials.gov) - Mar 3, 2015
P2, N=76, Completed, Sponsor: Auxilium Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Dec 2014
- ||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed: Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules (clinicaltrials.gov) - Oct 28, 2014
P2, N=90, Active, not recruiting, Sponsor: Auxilium Pharmaceuticals
Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Dec 2014 Recruiting --> Active, not recruiting
- ||| Trial completion, Enrollment change, Trial primary completion date: CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment (clinicaltrials.gov) - Oct 28, 2014
P=N/A, N=162, Completed, Sponsor: Auxilium Pharmaceuticals
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=300 --> 162 | Trial primary completion date: Mar 2017 --> Oct 2014
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed, Trial primary completion date: Registry of Patient With M. Dupuytren and Validation of the Brief MHQ (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=60, Active, not recruiting, Sponsor: Schulthess Klinik
Active, not recruiting --> Completed | N=300 --> 162 | Trial primary completion date: Mar 2017 --> Oct 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Sep 2014
- ||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
New P2 trial: Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules (clinicaltrials.gov) - Jul 18, 2014
P2, N=90, Recruiting, Sponsor: Auxilium Pharmaceuticals
- ||||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion, Trial primary completion date: Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures (clinicaltrials.gov) - Jul 18, 2014
P3, N=715, Completed, Sponsor: Auxilium Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Sep 2014 Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Sep 2013
- || Enrollment closed, Enrollment change: CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment (clinicaltrials.gov) - Jul 17, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: Auxilium Pharmaceuticals
Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Sep 2013 Recruiting --> Active, not recruiting | N=420 --> 300
- |||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion, Enrollment change: Retreatment of Recurrent Dupuytren's Contractures (clinicaltrials.gov) - Jul 17, 2014
P4, N=52, Completed, Sponsor: Auxilium Pharmaceuticals
Recruiting --> Active, not recruiting | N=420 --> 300 Active, not recruiting --> Completed | N=100 --> 52
- ||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion: Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859 (clinicaltrials.gov) - Jul 17, 2014
P=N/A, N=645, Completed, Sponsor: Auxilium Pharmaceuticals
Active, not recruiting --> Completed | N=100 --> 52 Active, not recruiting --> Completed
- ||||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion: CORD-J: Collagenase Option for Reduction of Dupuytren's Contracture in Japan (clinicaltrials.gov) - Jul 1, 2014
P3, N=69, Completed, Sponsor: Asahi Kasei Pharma Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Trial primary completion date: CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment (clinicaltrials.gov) - May 20, 2014
P=N/A, N=420, Recruiting, Sponsor: Auxilium Pharmaceuticals
Active, not recruiting --> Completed Trial primary completion date: Jan 2014 --> Mar 2017
- | Trial completion date: CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment (clinicaltrials.gov) - May 20, 2014
P=N/A, N=420, Recruiting, Sponsor: Auxilium Pharmaceuticals
Trial primary completion date: Jan 2014 --> Mar 2017 Trial completion date: Jan 2018 --> Jul 2017
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial withdrawal: Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease (clinicaltrials.gov) - Apr 3, 2014
P3, N=0, Withdrawn, Sponsor: University of Alberta
Trial completion date: Jan 2018 --> Jul 2017 Recruiting --> Withdrawn
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment change: Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease (clinicaltrials.gov) - Apr 3, 2014
P3, N=0, Withdrawn, Sponsor: University of Alberta
Recruiting --> Withdrawn N=300 --> 0
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment change: Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb (clinicaltrials.gov) - Mar 3, 2014
P4, N=7, Completed, Sponsor: Indiana Hand to Shoulder Center
N=300 --> 0 N=10 --> 7
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment change: Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture (clinicaltrials.gov) - Mar 3, 2014
P4, N=37, Completed, Sponsor: Indiana Hand to Shoulder Center
N=10 --> 7 N=60 --> 37
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion: Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb (clinicaltrials.gov) - Mar 3, 2014
P4, N=7, Completed, Sponsor: Indiana Hand to Shoulder Center
N=60 --> 37 Recruiting --> Completed
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion: Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture (clinicaltrials.gov) - Mar 3, 2014
P4, N=37, Completed, Sponsor: Indiana Hand to Shoulder Center
Recruiting --> Completed Recruiting --> Completed
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed: Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture (clinicaltrials.gov) - Mar 2, 2014
P=N/A, N=50, Active, not recruiting, Sponsor: Jeppe Lange, MD
Recruiting --> Completed Recruiting --> Active, not recruiting
- | triamcinolone acetonide / Generic mfg.
Trial completion: Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture (clinicaltrials.gov) - Dec 11, 2013
P3, N=51, Completed, Sponsor: Sunnybrook Health Sciences Centre
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed: Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures (clinicaltrials.gov) - Aug 19, 2013
P3, N=600, Active, not recruiting, Sponsor: Auxilium Pharmaceuticals
Recruiting --> Completed Recruiting --> Active, not recruiting
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment open: Registry of Patient With M. Dupuytren and Validation of the Brief MHQ (clinicaltrials.gov) - Aug 18, 2013
P=N/A, N=60, Recruiting, Sponsor: Schulthess Klinik
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Trial completion: ReDuCTO: Registry of Dupuytren's Contracture Treatment Outcomes (clinicaltrials.gov) - Apr 28, 2013
P=N/A, N=87, Completed, Sponsor: Technische Universit
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed: CORD-J: Collagenase Option for Reduction of Dupuytren's Contracture in Japan (clinicaltrials.gov) - Apr 11, 2013
P3, N=69, Active, not recruiting, Sponsor: Asahi Kasei Pharma Corporation
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion: Administration of Two Injections for Multiple Dupuytren's Contractures (clinicaltrials.gov) - Mar 19, 2013
P3, N=60, Completed, Sponsor: Auxilium Pharmaceuticals
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed: Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859 (clinicaltrials.gov) - Mar 18, 2013
P=N/A, N=600, Active, not recruiting, Sponsor: Auxilium Pharmaceuticals
Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
New P3 trial: Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease (clinicaltrials.gov) - Jan 24, 2013
P3, N=0, Withdrawn, Sponsor: University of Alberta
- ||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment closed: Retreatment of Recurrent Dupuytren's Contractures (clinicaltrials.gov) - Dec 11, 2012
P4, N=100, Active, not recruiting, Sponsor: Auxilium Pharmaceuticals
Enrolling by invitation --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
- ||||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion: POINT X: Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex) (clinicaltrials.gov) - Nov 27, 2012
P3, N=254, Completed, Sponsor: Pfizer
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- ||| Clinical: CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=420, Recruiting, Sponsor: Auxilium Pharmaceuticals
- |||||||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
New P3 trial: Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures (clinicaltrials.gov) - Aug 27, 2012
P3, N=600, Active, not recruiting, Sponsor: Auxilium Pharmaceuticals
- |||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Enrollment open: Post Approval Commitment Study (clinicaltrials.gov) - Jul 16, 2012
P4, N=250, Recruiting, Sponsor: Auxilium Pharmaceuticals
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
New P3 trial: CORD-J: Collagenase Option for Reduction of Dupuytren's Contracture in Japan (clinicaltrials.gov) - Apr 26, 2012
P3, N=69, Active, not recruiting, Sponsor: Asahi Kasei Pharma Corporation
- | Trial completion: Evaluation of the Efficiency of Autologous Platelet Gel (Platelet Rich Fibrin) Obtained From Own Patients' Blood Versus Vaselitulle in Dupuytren's Disease Postoperative Wound Healing (clinicaltrials.gov) - Mar 18, 2012
P2/3, N=80, Completed, Sponsor: Centre Hospitalier Universitaire de Nice
Not yet recruiting --> Recruiting Recruiting --> Completed
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
Trial completion: MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex (clinicaltrials.gov) - Mar 14, 2012
P4, N=5, Completed, Sponsor: Scott Wolfe
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
New P4 trial: Retreatment of Recurrent Dupuytren's Contractures (clinicaltrials.gov) - Dec 21, 2011
P4, N=100, Active, not recruiting, Sponsor: Auxilium Pharmaceuticals
- Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
New P4 trial: MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex (clinicaltrials.gov) - Oct 10, 2011
P4, N=5, Completed, Sponsor: Scott Wolfe
- ||||| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
New P4 trial: Post Approval Commitment Study (clinicaltrials.gov) - Sep 29, 2011
P4, N=250, Recruiting, Sponsor: Auxilium Pharmaceuticals